neurovascular and neurodegenerative disease mechanisms
We have built robust experimental pipelines that allow us to interrogate disease phenotypes in our in vitro models, with complementary and follow-up analyses in animal models and human tissue samples. The in vivo and tissue data also feed back into in vitro model development to better recapitulate the disease being studied. Currently, our interests are centered around Alzheimer’s disease, cerebral amyloid angiopathy, and general tauopathies. We are also very interested in any condition that may yield blood-brain barrier dysfunction as a cause or consequence of disease.
Relevant contacts
Hyosung Kim, Lauren Drake, Andrew Kjar, Rebecca Embalabala, Elaina Ziehm
Relevant publications